OUABAIN RECEPTOR-BINDING OF HYDROXYPROGESTERONE DERIVATIVES

被引:30
作者
CHOW, E
KIM, RSS
LABELLA, FS
QUEEN, G
机构
[1] Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba
关键词
D O I
10.1111/j.1476-5381.1979.tb08686.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A specific and sensitive radioreceptor assay has been devised which is based on high affinity, saturable binding of 9 nm [3H]‐ouabain to the total particulate fraction isolated from dog heart. Ouabain and other cardiac glycosides, including the aglycones, were about equipotent in their ability to displace [3H]‐ouabain from its receptor, the IC50s ranging from 10 to 30 nm. The only other substances found to compete significantly in the assay were derivatives of hydroxy‐progesterone having a 17α‐acetate substituent: chlormadinone acetate, megestrol acetate, cyproterone acetate and medroxyprogesterone acetate, with IC50s of 2, 7.4, 9 and 21 μm, respectively. Prednisolone‐3,20‐bisguanyl‐hydrazone, reported to have inotropic activity, gave an IC50 of 6.4 μm. Cyproterone‐17α‐OH was less active (IC50 90 μm) than cyproterone‐17α‐acetate. A large number of peptide and protein hormones, steroid hormones and their metabolites, amines, and drugs were inactive. 1979 British Pharmacological Society
引用
收藏
页码:345 / 352
页数:8
相关论文
共 34 条
[1]  
AKERA T, 1970, J PHARMACOL EXP THER, V173, P145
[2]   MEMBRANE ADENOSINE-TRIPHOSPHATASE - DIGITALIS RECEPTOR [J].
AKERA, T .
SCIENCE, 1977, 198 (4317) :569-574
[3]  
AKERA T, 1969, J PHARMACOL EXP THER, V170, P17
[4]  
AKERA T, 1976, MOL PHARMACOL, V12, P101
[5]   INOTROPIC ACTION OF DIGITALIS AND ION-TRANSPORT [J].
AKERA, T ;
BRODY, TM .
LIFE SCIENCES, 1976, 18 (02) :135-142
[6]  
ALLEN JC, 1969, J PHARMACOL EXP THER, V168, P42
[7]  
BESCH HR, 1970, J PHARMACOL EXP THER, V171, P1
[8]  
BRODY TM, 1975, P W PHARMACOL SOC, V18, P8
[9]   KINETICS STUDIES ON INTERACTION BETWEEN OUABAIN AND (NA+,K+)-ATPASE [J].
CHOI, YR ;
AKERA, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1977, 481 (02) :648-659
[10]  
DRANSFEL.H, 1967, ARCH INT PHARMACOD T, V166, P342